nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—CYP3A7—Dexamethasone—psoriatic arthritis	0.0887	0.128	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0887	0.128	CbGbCtD
Ondansetron—CYP2E1—Dexamethasone—psoriatic arthritis	0.0857	0.124	CbGbCtD
Ondansetron—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0686	0.0992	CbGbCtD
Ondansetron—CYP3A5—Dexamethasone—psoriatic arthritis	0.0666	0.0962	CbGbCtD
Ondansetron—CYP3A4—Triamcinolone—psoriatic arthritis	0.052	0.0752	CbGbCtD
Ondansetron—CYP2C9—Dexamethasone—psoriatic arthritis	0.0446	0.0645	CbGbCtD
Ondansetron—CYP3A4—Betamethasone—psoriatic arthritis	0.0446	0.0645	CbGbCtD
Ondansetron—CYP3A4—Prednisolone—psoriatic arthritis	0.044	0.0636	CbGbCtD
Ondansetron—CYP3A4—Prednisone—psoriatic arthritis	0.0416	0.0601	CbGbCtD
Ondansetron—CYP2D6—Dexamethasone—psoriatic arthritis	0.0408	0.059	CbGbCtD
Ondansetron—CYP3A4—Dexamethasone—psoriatic arthritis	0.026	0.0375	CbGbCtD
Ondansetron—Haemorrhage—Dexamethasone—psoriatic arthritis	0.001	0.00325	CcSEcCtD
Ondansetron—Haemorrhage—Betamethasone—psoriatic arthritis	0.001	0.00325	CcSEcCtD
Ondansetron—Angiopathy—Methylprednisolone—psoriatic arthritis	0.001	0.00325	CcSEcCtD
Ondansetron—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000996	0.00323	CcSEcCtD
Ondansetron—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000994	0.00323	CcSEcCtD
Ondansetron—Arrhythmia—Triamcinolone—psoriatic arthritis	0.000987	0.0032	CcSEcCtD
Ondansetron—Vision blurred—Prednisolone—psoriatic arthritis	0.000986	0.0032	CcSEcCtD
Ondansetron—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.000985	0.0032	CcSEcCtD
Ondansetron—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000974	0.00316	CcSEcCtD
Ondansetron—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000971	0.00315	CcSEcCtD
Ondansetron—Visual impairment—Dexamethasone—psoriatic arthritis	0.000967	0.00314	CcSEcCtD
Ondansetron—Visual impairment—Betamethasone—psoriatic arthritis	0.000967	0.00314	CcSEcCtD
Ondansetron—Erythema—Triamcinolone—psoriatic arthritis	0.000962	0.00312	CcSEcCtD
Ondansetron—Erythema—Methylprednisolone—psoriatic arthritis	0.00096	0.00312	CcSEcCtD
Ondansetron—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000959	0.00311	CcSEcCtD
Ondansetron—Angioedema—Prednisolone—psoriatic arthritis	0.000956	0.0031	CcSEcCtD
Ondansetron—Myocardial infarction—Prednisone—psoriatic arthritis	0.000954	0.00309	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00095	0.00308	CcSEcCtD
Ondansetron—Malaise—Prednisolone—psoriatic arthritis	0.000944	0.00306	CcSEcCtD
Ondansetron—Syncope—Prednisolone—psoriatic arthritis	0.000938	0.00304	CcSEcCtD
Ondansetron—Eye disorder—Dexamethasone—psoriatic arthritis	0.000937	0.00304	CcSEcCtD
Ondansetron—Eye disorder—Betamethasone—psoriatic arthritis	0.000937	0.00304	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00092	0.00298	CcSEcCtD
Ondansetron—Asthma—Methotrexate—psoriatic arthritis	0.000912	0.00296	CcSEcCtD
Ondansetron—Angiopathy—Dexamethasone—psoriatic arthritis	0.00091	0.00295	CcSEcCtD
Ondansetron—Angiopathy—Betamethasone—psoriatic arthritis	0.00091	0.00295	CcSEcCtD
Ondansetron—Convulsion—Prednisolone—psoriatic arthritis	0.000907	0.00294	CcSEcCtD
Ondansetron—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000896	0.00291	CcSEcCtD
Ondansetron—Arrhythmia—Betamethasone—psoriatic arthritis	0.000896	0.00291	CcSEcCtD
Ondansetron—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000893	0.0029	CcSEcCtD
Ondansetron—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000891	0.00289	CcSEcCtD
Ondansetron—Bradycardia—Prednisone—psoriatic arthritis	0.000889	0.00289	CcSEcCtD
Ondansetron—Discomfort—Prednisolone—psoriatic arthritis	0.00088	0.00286	CcSEcCtD
Ondansetron—Angioedema—Triamcinolone—psoriatic arthritis	0.000879	0.00285	CcSEcCtD
Ondansetron—Haemoglobin—Prednisone—psoriatic arthritis	0.000878	0.00285	CcSEcCtD
Ondansetron—Angioedema—Methylprednisolone—psoriatic arthritis	0.000877	0.00285	CcSEcCtD
Ondansetron—Haemorrhage—Prednisone—psoriatic arthritis	0.000873	0.00283	CcSEcCtD
Ondansetron—Erythema—Dexamethasone—psoriatic arthritis	0.000873	0.00283	CcSEcCtD
Ondansetron—Erythema—Betamethasone—psoriatic arthritis	0.000873	0.00283	CcSEcCtD
Ondansetron—Malaise—Triamcinolone—psoriatic arthritis	0.000868	0.00282	CcSEcCtD
Ondansetron—Malaise—Methylprednisolone—psoriatic arthritis	0.000866	0.00281	CcSEcCtD
Ondansetron—Syncope—Triamcinolone—psoriatic arthritis	0.000863	0.0028	CcSEcCtD
Ondansetron—Syncope—Methylprednisolone—psoriatic arthritis	0.000861	0.00279	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000854	0.00277	CcSEcCtD
Ondansetron—Dysuria—Methotrexate—psoriatic arthritis	0.000853	0.00277	CcSEcCtD
Ondansetron—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000846	0.00274	CcSEcCtD
Ondansetron—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000844	0.00274	CcSEcCtD
Ondansetron—Shock—Prednisolone—psoriatic arthritis	0.00084	0.00273	CcSEcCtD
Ondansetron—Cough—Triamcinolone—psoriatic arthritis	0.00084	0.00272	CcSEcCtD
Ondansetron—Convulsion—Triamcinolone—psoriatic arthritis	0.000834	0.00271	CcSEcCtD
Ondansetron—Tachycardia—Prednisolone—psoriatic arthritis	0.000833	0.0027	CcSEcCtD
Ondansetron—Convulsion—Methylprednisolone—psoriatic arthritis	0.000832	0.0027	CcSEcCtD
Ondansetron—Eye disorder—Prednisone—psoriatic arthritis	0.000816	0.00265	CcSEcCtD
Ondansetron—Anxiety—Methylprednisolone—psoriatic arthritis	0.000815	0.00264	CcSEcCtD
Ondansetron—Drowsiness—Methotrexate—psoriatic arthritis	0.000813	0.00264	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000812	0.00263	CcSEcCtD
Ondansetron—Flushing—Prednisone—psoriatic arthritis	0.000811	0.00263	CcSEcCtD
Ondansetron—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00081	0.00263	CcSEcCtD
Ondansetron—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00081	0.00263	CcSEcCtD
Ondansetron—Discomfort—Triamcinolone—psoriatic arthritis	0.000809	0.00263	CcSEcCtD
Ondansetron—Discomfort—Methylprednisolone—psoriatic arthritis	0.000808	0.00262	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000806	0.00262	CcSEcCtD
Ondansetron—Dry mouth—Triamcinolone—psoriatic arthritis	0.000801	0.0026	CcSEcCtD
Ondansetron—Angioedema—Betamethasone—psoriatic arthritis	0.000798	0.00259	CcSEcCtD
Ondansetron—Angioedema—Dexamethasone—psoriatic arthritis	0.000798	0.00259	CcSEcCtD
Ondansetron—Angiopathy—Prednisone—psoriatic arthritis	0.000792	0.00257	CcSEcCtD
Ondansetron—Immune system disorder—Prednisone—psoriatic arthritis	0.000789	0.00256	CcSEcCtD
Ondansetron—Malaise—Betamethasone—psoriatic arthritis	0.000787	0.00255	CcSEcCtD
Ondansetron—Malaise—Dexamethasone—psoriatic arthritis	0.000787	0.00255	CcSEcCtD
Ondansetron—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000785	0.00255	CcSEcCtD
Ondansetron—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000784	0.00254	CcSEcCtD
Ondansetron—Syncope—Dexamethasone—psoriatic arthritis	0.000783	0.00254	CcSEcCtD
Ondansetron—Syncope—Betamethasone—psoriatic arthritis	0.000783	0.00254	CcSEcCtD
Ondansetron—Arrhythmia—Prednisone—psoriatic arthritis	0.00078	0.00253	CcSEcCtD
Ondansetron—Shock—Triamcinolone—psoriatic arthritis	0.000773	0.00251	CcSEcCtD
Ondansetron—Shock—Methylprednisolone—psoriatic arthritis	0.000771	0.0025	CcSEcCtD
Ondansetron—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000769	0.0025	CcSEcCtD
Ondansetron—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000768	0.00249	CcSEcCtD
Ondansetron—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000767	0.00249	CcSEcCtD
Ondansetron—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000767	0.00249	CcSEcCtD
Ondansetron—Paraesthesia—Prednisolone—psoriatic arthritis	0.000767	0.00249	CcSEcCtD
Ondansetron—Tachycardia—Triamcinolone—psoriatic arthritis	0.000766	0.00249	CcSEcCtD
Ondansetron—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000765	0.00248	CcSEcCtD
Ondansetron—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000761	0.00247	CcSEcCtD
Ondansetron—Erythema—Prednisone—psoriatic arthritis	0.00076	0.00247	CcSEcCtD
Ondansetron—Convulsion—Dexamethasone—psoriatic arthritis	0.000756	0.00245	CcSEcCtD
Ondansetron—Convulsion—Betamethasone—psoriatic arthritis	0.000756	0.00245	CcSEcCtD
Ondansetron—Anxiety—Betamethasone—psoriatic arthritis	0.000741	0.0024	CcSEcCtD
Ondansetron—Anxiety—Dexamethasone—psoriatic arthritis	0.000741	0.0024	CcSEcCtD
Ondansetron—Discomfort—Dexamethasone—psoriatic arthritis	0.000734	0.00238	CcSEcCtD
Ondansetron—Discomfort—Betamethasone—psoriatic arthritis	0.000734	0.00238	CcSEcCtD
Ondansetron—Haemoglobin—Methotrexate—psoriatic arthritis	0.000734	0.00238	CcSEcCtD
Ondansetron—Hypotension—Methylprednisolone—psoriatic arthritis	0.000732	0.00238	CcSEcCtD
Ondansetron—Pain—Prednisolone—psoriatic arthritis	0.00073	0.00237	CcSEcCtD
Ondansetron—Haemorrhage—Methotrexate—psoriatic arthritis	0.00073	0.00237	CcSEcCtD
Ondansetron—Vision blurred—Prednisone—psoriatic arthritis	0.000717	0.00232	CcSEcCtD
Ondansetron—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000713	0.00231	CcSEcCtD
Ondansetron—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000713	0.00231	CcSEcCtD
Ondansetron—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000705	0.00229	CcSEcCtD
Ondansetron—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000705	0.00229	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000704	0.00228	CcSEcCtD
Ondansetron—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000704	0.00228	CcSEcCtD
Ondansetron—Visual impairment—Methotrexate—psoriatic arthritis	0.000703	0.00228	CcSEcCtD
Ondansetron—Shock—Dexamethasone—psoriatic arthritis	0.000701	0.00227	CcSEcCtD
Ondansetron—Shock—Betamethasone—psoriatic arthritis	0.000701	0.00227	CcSEcCtD
Ondansetron—Dyspnoea—Triamcinolone—psoriatic arthritis	0.0007	0.00227	CcSEcCtD
Ondansetron—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000699	0.00227	CcSEcCtD
Ondansetron—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000699	0.00227	CcSEcCtD
Ondansetron—Agitation—Prednisone—psoriatic arthritis	0.000699	0.00227	CcSEcCtD
Ondansetron—Tachycardia—Betamethasone—psoriatic arthritis	0.000695	0.00226	CcSEcCtD
Ondansetron—Tachycardia—Dexamethasone—psoriatic arthritis	0.000695	0.00226	CcSEcCtD
Ondansetron—Angioedema—Prednisone—psoriatic arthritis	0.000695	0.00225	CcSEcCtD
Ondansetron—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00069	0.00224	CcSEcCtD
Ondansetron—Malaise—Prednisone—psoriatic arthritis	0.000686	0.00222	CcSEcCtD
Ondansetron—Eye disorder—Methotrexate—psoriatic arthritis	0.000682	0.00221	CcSEcCtD
Ondansetron—Syncope—Prednisone—psoriatic arthritis	0.000682	0.00221	CcSEcCtD
Ondansetron—Urticaria—Prednisolone—psoriatic arthritis	0.000678	0.0022	CcSEcCtD
Ondansetron—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000677	0.0022	CcSEcCtD
Ondansetron—Fatigue—Triamcinolone—psoriatic arthritis	0.000677	0.0022	CcSEcCtD
Ondansetron—Fatigue—Methylprednisolone—psoriatic arthritis	0.000676	0.00219	CcSEcCtD
Ondansetron—Pain—Triamcinolone—psoriatic arthritis	0.000672	0.00218	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisone—psoriatic arthritis	0.000668	0.00217	CcSEcCtD
Ondansetron—Hypotension—Dexamethasone—psoriatic arthritis	0.000666	0.00216	CcSEcCtD
Ondansetron—Hypotension—Betamethasone—psoriatic arthritis	0.000666	0.00216	CcSEcCtD
Ondansetron—Angiopathy—Methotrexate—psoriatic arthritis	0.000662	0.00215	CcSEcCtD
Ondansetron—Immune system disorder—Methotrexate—psoriatic arthritis	0.000659	0.00214	CcSEcCtD
Ondansetron—Convulsion—Prednisone—psoriatic arthritis	0.000659	0.00214	CcSEcCtD
Ondansetron—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000658	0.00213	CcSEcCtD
Ondansetron—Chills—Methotrexate—psoriatic arthritis	0.000655	0.00213	CcSEcCtD
Ondansetron—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000647	0.0021	CcSEcCtD
Ondansetron—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000646	0.0021	CcSEcCtD
Ondansetron—Anxiety—Prednisone—psoriatic arthritis	0.000645	0.00209	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000643	0.00209	CcSEcCtD
Ondansetron—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000641	0.00208	CcSEcCtD
Ondansetron—Paraesthesia—Betamethasone—psoriatic arthritis	0.00064	0.00208	CcSEcCtD
Ondansetron—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00064	0.00208	CcSEcCtD
Ondansetron—Discomfort—Prednisone—psoriatic arthritis	0.00064	0.00208	CcSEcCtD
Ondansetron—Erythema—Methotrexate—psoriatic arthritis	0.000635	0.00206	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000629	0.00204	CcSEcCtD
Ondansetron—Urticaria—Triamcinolone—psoriatic arthritis	0.000624	0.00202	CcSEcCtD
Ondansetron—Urticaria—Methylprednisolone—psoriatic arthritis	0.000622	0.00202	CcSEcCtD
Ondansetron—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000621	0.00201	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000621	0.00201	CcSEcCtD
Ondansetron—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000619	0.00201	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000615	0.002	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000615	0.002	CcSEcCtD
Ondansetron—Fatigue—Betamethasone—psoriatic arthritis	0.000614	0.00199	CcSEcCtD
Ondansetron—Fatigue—Dexamethasone—psoriatic arthritis	0.000614	0.00199	CcSEcCtD
Ondansetron—Shock—Prednisone—psoriatic arthritis	0.000611	0.00198	CcSEcCtD
Ondansetron—Pain—Betamethasone—psoriatic arthritis	0.000609	0.00198	CcSEcCtD
Ondansetron—Pain—Dexamethasone—psoriatic arthritis	0.000609	0.00198	CcSEcCtD
Ondansetron—Nervous system disorder—Prednisone—psoriatic arthritis	0.000609	0.00197	CcSEcCtD
Ondansetron—Tachycardia—Prednisone—psoriatic arthritis	0.000606	0.00197	CcSEcCtD
Ondansetron—Skin disorder—Prednisone—psoriatic arthritis	0.000603	0.00196	CcSEcCtD
Ondansetron—Vision blurred—Methotrexate—psoriatic arthritis	0.000599	0.00194	CcSEcCtD
Ondansetron—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00059	0.00191	CcSEcCtD
Ondansetron—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000587	0.00191	CcSEcCtD
Ondansetron—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000587	0.00191	CcSEcCtD
Ondansetron—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000583	0.00189	CcSEcCtD
Ondansetron—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000583	0.00189	CcSEcCtD
Ondansetron—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000579	0.00188	CcSEcCtD
Ondansetron—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000577	0.00187	CcSEcCtD
Ondansetron—Malaise—Methotrexate—psoriatic arthritis	0.000573	0.00186	CcSEcCtD
Ondansetron—Urticaria—Dexamethasone—psoriatic arthritis	0.000566	0.00184	CcSEcCtD
Ondansetron—Urticaria—Betamethasone—psoriatic arthritis	0.000566	0.00184	CcSEcCtD
Ondansetron—Dizziness—Prednisolone—psoriatic arthritis	0.000565	0.00183	CcSEcCtD
Ondansetron—Asthenia—Triamcinolone—psoriatic arthritis	0.000563	0.00183	CcSEcCtD
Ondansetron—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000563	0.00183	CcSEcCtD
Ondansetron—Abdominal pain—Betamethasone—psoriatic arthritis	0.000563	0.00183	CcSEcCtD
Ondansetron—Body temperature increased—Betamethasone—psoriatic arthritis	0.000563	0.00183	CcSEcCtD
Ondansetron—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000563	0.00183	CcSEcCtD
Ondansetron—Asthenia—Methylprednisolone—psoriatic arthritis	0.000562	0.00182	CcSEcCtD
Ondansetron—Paraesthesia—Prednisone—psoriatic arthritis	0.000557	0.00181	CcSEcCtD
Ondansetron—Pruritus—Triamcinolone—psoriatic arthritis	0.000556	0.0018	CcSEcCtD
Ondansetron—Cough—Methotrexate—psoriatic arthritis	0.000555	0.0018	CcSEcCtD
Ondansetron—Pruritus—Methylprednisolone—psoriatic arthritis	0.000554	0.0018	CcSEcCtD
Ondansetron—Convulsion—Methotrexate—psoriatic arthritis	0.000551	0.00179	CcSEcCtD
Ondansetron—Chest pain—Methotrexate—psoriatic arthritis	0.000541	0.00176	CcSEcCtD
Ondansetron—Rash—Prednisolone—psoriatic arthritis	0.000538	0.00175	CcSEcCtD
Ondansetron—Dermatitis—Prednisolone—psoriatic arthritis	0.000538	0.00175	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000537	0.00174	CcSEcCtD
Ondansetron—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000536	0.00174	CcSEcCtD
Ondansetron—Fatigue—Prednisone—psoriatic arthritis	0.000535	0.00174	CcSEcCtD
Ondansetron—Headache—Prednisolone—psoriatic arthritis	0.000535	0.00174	CcSEcCtD
Ondansetron—Discomfort—Methotrexate—psoriatic arthritis	0.000535	0.00173	CcSEcCtD
Ondansetron—Constipation—Prednisone—psoriatic arthritis	0.000531	0.00172	CcSEcCtD
Ondansetron—Dizziness—Triamcinolone—psoriatic arthritis	0.000519	0.00168	CcSEcCtD
Ondansetron—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000519	0.00168	CcSEcCtD
Ondansetron—Dizziness—Methylprednisolone—psoriatic arthritis	0.000518	0.00168	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisone—psoriatic arthritis	0.000511	0.00166	CcSEcCtD
Ondansetron—Asthenia—Dexamethasone—psoriatic arthritis	0.000511	0.00166	CcSEcCtD
Ondansetron—Asthenia—Betamethasone—psoriatic arthritis	0.000511	0.00166	CcSEcCtD
Ondansetron—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000509	0.00165	CcSEcCtD
Ondansetron—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000507	0.00165	CcSEcCtD
Ondansetron—Pruritus—Betamethasone—psoriatic arthritis	0.000504	0.00164	CcSEcCtD
Ondansetron—Pruritus—Dexamethasone—psoriatic arthritis	0.000504	0.00164	CcSEcCtD
Ondansetron—Skin disorder—Methotrexate—psoriatic arthritis	0.000504	0.00163	CcSEcCtD
Ondansetron—Vomiting—Triamcinolone—psoriatic arthritis	0.000499	0.00162	CcSEcCtD
Ondansetron—Vomiting—Methylprednisolone—psoriatic arthritis	0.000498	0.00162	CcSEcCtD
Ondansetron—Rash—Triamcinolone—psoriatic arthritis	0.000495	0.00161	CcSEcCtD
Ondansetron—Dermatitis—Triamcinolone—psoriatic arthritis	0.000495	0.00161	CcSEcCtD
Ondansetron—Rash—Methylprednisolone—psoriatic arthritis	0.000494	0.0016	CcSEcCtD
Ondansetron—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000494	0.0016	CcSEcCtD
Ondansetron—Urticaria—Prednisone—psoriatic arthritis	0.000493	0.0016	CcSEcCtD
Ondansetron—Headache—Triamcinolone—psoriatic arthritis	0.000492	0.0016	CcSEcCtD
Ondansetron—Headache—Methylprednisolone—psoriatic arthritis	0.000491	0.00159	CcSEcCtD
Ondansetron—Abdominal pain—Prednisone—psoriatic arthritis	0.000491	0.00159	CcSEcCtD
Ondansetron—Body temperature increased—Prednisone—psoriatic arthritis	0.000491	0.00159	CcSEcCtD
Ondansetron—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000488	0.00158	CcSEcCtD
Ondansetron—Diarrhoea—Betamethasone—psoriatic arthritis	0.000488	0.00158	CcSEcCtD
Ondansetron—Hypotension—Methotrexate—psoriatic arthritis	0.000485	0.00157	CcSEcCtD
Ondansetron—Dizziness—Betamethasone—psoriatic arthritis	0.000471	0.00153	CcSEcCtD
Ondansetron—Dizziness—Dexamethasone—psoriatic arthritis	0.000471	0.00153	CcSEcCtD
Ondansetron—Paraesthesia—Methotrexate—psoriatic arthritis	0.000466	0.00151	CcSEcCtD
Ondansetron—Dyspnoea—Methotrexate—psoriatic arthritis	0.000462	0.0015	CcSEcCtD
Ondansetron—Somnolence—Methotrexate—psoriatic arthritis	0.000461	0.0015	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisone—psoriatic arthritis	0.000457	0.00148	CcSEcCtD
Ondansetron—Vomiting—Dexamethasone—psoriatic arthritis	0.000453	0.00147	CcSEcCtD
Ondansetron—Vomiting—Betamethasone—psoriatic arthritis	0.000453	0.00147	CcSEcCtD
Ondansetron—Rash—Betamethasone—psoriatic arthritis	0.000449	0.00146	CcSEcCtD
Ondansetron—Rash—Dexamethasone—psoriatic arthritis	0.000449	0.00146	CcSEcCtD
Ondansetron—Dermatitis—Betamethasone—psoriatic arthritis	0.000449	0.00146	CcSEcCtD
Ondansetron—Dermatitis—Dexamethasone—psoriatic arthritis	0.000449	0.00146	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000448	0.00145	CcSEcCtD
Ondansetron—Fatigue—Methotrexate—psoriatic arthritis	0.000447	0.00145	CcSEcCtD
Ondansetron—Headache—Betamethasone—psoriatic arthritis	0.000446	0.00145	CcSEcCtD
Ondansetron—Headache—Dexamethasone—psoriatic arthritis	0.000446	0.00145	CcSEcCtD
Ondansetron—Asthenia—Prednisone—psoriatic arthritis	0.000445	0.00144	CcSEcCtD
Ondansetron—Pain—Methotrexate—psoriatic arthritis	0.000443	0.00144	CcSEcCtD
Ondansetron—Pruritus—Prednisone—psoriatic arthritis	0.000439	0.00142	CcSEcCtD
Ondansetron—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000427	0.00139	CcSEcCtD
Ondansetron—Diarrhoea—Prednisone—psoriatic arthritis	0.000425	0.00138	CcSEcCtD
Ondansetron—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000424	0.00138	CcSEcCtD
Ondansetron—Urticaria—Methotrexate—psoriatic arthritis	0.000412	0.00134	CcSEcCtD
Ondansetron—Dizziness—Prednisone—psoriatic arthritis	0.00041	0.00133	CcSEcCtD
Ondansetron—Abdominal pain—Methotrexate—psoriatic arthritis	0.00041	0.00133	CcSEcCtD
Ondansetron—Body temperature increased—Methotrexate—psoriatic arthritis	0.00041	0.00133	CcSEcCtD
Ondansetron—Vomiting—Prednisone—psoriatic arthritis	0.000395	0.00128	CcSEcCtD
Ondansetron—Rash—Prednisone—psoriatic arthritis	0.000391	0.00127	CcSEcCtD
Ondansetron—Dermatitis—Prednisone—psoriatic arthritis	0.000391	0.00127	CcSEcCtD
Ondansetron—Headache—Prednisone—psoriatic arthritis	0.000389	0.00126	CcSEcCtD
Ondansetron—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000382	0.00124	CcSEcCtD
Ondansetron—Asthenia—Methotrexate—psoriatic arthritis	0.000372	0.00121	CcSEcCtD
Ondansetron—Pruritus—Methotrexate—psoriatic arthritis	0.000367	0.00119	CcSEcCtD
Ondansetron—Diarrhoea—Methotrexate—psoriatic arthritis	0.000355	0.00115	CcSEcCtD
Ondansetron—Dizziness—Methotrexate—psoriatic arthritis	0.000343	0.00111	CcSEcCtD
Ondansetron—Vomiting—Methotrexate—psoriatic arthritis	0.00033	0.00107	CcSEcCtD
Ondansetron—Rash—Methotrexate—psoriatic arthritis	0.000327	0.00106	CcSEcCtD
Ondansetron—Dermatitis—Methotrexate—psoriatic arthritis	0.000327	0.00106	CcSEcCtD
Ondansetron—Headache—Methotrexate—psoriatic arthritis	0.000325	0.00105	CcSEcCtD
